|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Nabriva Therapeutics plc (NBRV)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-12-24 Purchase |
2018-12-27 4:05 pm |
Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director |
53,000 | $1.31 | $69,430 | 53,000 (Direct) |
View |
| 2018-07-31 Purchase |
2018-08-02 5:52 pm |
Nabriva Therapeutics plc | NBRV | Talbot George Harrison Director |
14,500 | $2.75 | $39,875 | 47,640 (Direct) |
View |
| 2018-07-31 Purchase |
2018-08-02 5:51 pm |
Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director |
36,000 | $2.75 | $99,000 | 36,000 (Direct) |
View |
| 2018-06-23 Purchase |
2018-06-26 09:09 am |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. Chief Scientific Officer |
10,000 | $3.82 | $38,200 | 22,740 (Direct) |
View |
| 2018-06-22 Purchase |
2018-06-25 09:47 am |
Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer |
5,500 | $3.73 | $20,515 | 5,500 (Direct) |
View |
| 2018-06-22 Purchase |
2018-06-25 09:47 am |
Nabriva Therapeutics plc | NBRV | Broom Colin MD CEO |
5,000 | $3.72 | $18,600 | 102,151 (Indirect Direct) |
View |
| 2018-05-23 Purchase |
2018-05-29 1:48 pm |
Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer |
2,160 | $4.6 | $9,936 | 3,719 (Direct) |
View |
| 2018-05-23 Purchase |
2018-05-23 8:38 pm |
Nabriva Therapeutics plc | NBRV | Sender Gary CFO |
2,000 | $4.57 | $9,140 | 6,200 (Direct) |
View |
| 2018-05-23 Purchase |
2018-05-23 8:37 pm |
Nabriva Therapeutics plc | NBRV | Webster Stephen W Director |
8,000 | $4.59 | $36,720 | 8,000 (Direct) |
View |
| 2018-05-23 Purchase |
2018-05-23 8:36 pm |
Nabriva Therapeutics plc | NBRV | Broom Colin MD CEO |
10,000 | $4.6 | $46,000 | 97,151 (Indirect Direct) |
View |
| 2018-05-23 Purchase |
2018-05-23 12:29 pm |
Nabriva Therapeutics plc | NBRV | Crotty Robert General Counsel & Secretary |
10,000 | $4.48 | $44,800 | 10,000 (Direct) |
View |
| 2017-11-29 Purchase |
2017-12-01 4:07 pm |
Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer |
1,569 | $6.29 | $9,869 | 1,569 (Direct) |
View |
| 2017-09-22 Purchase |
2017-09-26 5:01 pm |
Nabriva Therapeutics plc | NBRV | Sender Gary CFO |
2,000 | $8.21 | $16,420 | 4,200 (Direct) |
View |
| 2017-09-22 Purchase |
2017-09-26 5:01 pm |
Nabriva Therapeutics plc | NBRV | Broom Colin MD CEO |
2,588 | $8.35 | $21,610 | 87,151 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-01-31 Option Award |
2019-02-04 4:07 pm |
N/A 2029-01-31 |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO |
278,400 | $0 | 278,400 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:07 pm |
N/A 2023-01-31 |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO |
105,750 | $0 | 278,400 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:07 pm |
N/A 2029-01-31 |
Nabriva Therapeutics plc | NBRV | Sender Gary CFO |
138,200 | $0 | 138,200 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:07 pm |
N/A 2023-01-31 |
Nabriva Therapeutics plc | NBRV | Sender Gary CFO |
52,500 | $0 | 138,200 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:06 pm |
N/A 2029-01-31 |
Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer |
138,200 | $0 | 138,200 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:06 pm |
N/A 2023-01-31 |
Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer |
52,500 | $0 | 138,200 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:06 pm |
N/A 2029-01-31 |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
138,200 | $0 | 138,200 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:06 pm |
N/A 2023-01-31 |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
52,500 | $0 | 138,200 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:06 pm |
N/A 2029-01-31 |
Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer |
235,000 | $0 | 235,000 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:06 pm |
N/A 2023-01-31 |
Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer |
52,500 | $0 | 235,000 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:05 pm |
N/A 2029-01-31 |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO |
429,800 | $0 | 429,800 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:05 pm |
N/A 2023-01-31 |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO |
163,250 | $0 | 429,800 (Direct) |
View |
| 2018-08-02 Option Award |
2018-08-03 7:31 pm |
N/A 2028-08-02 |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO |
7,500 | $0 | 32,000 (Direct) |
View |
| 2018-08-02 Option Award |
2018-08-03 7:31 pm |
N/A 2020-01-31 |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO |
32,000 | $0 | 32,000 (Direct) |
View |
| 2018-08-01 Option Award |
2018-08-02 5:53 pm |
N/A 2028-08-01 |
Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2018-07-31 Option Award |
2018-08-02 5:51 pm |
N/A 2028-08-01 |
Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director |
15,000 | $0 | 36,000 (Direct) |
View |
| 2018-07-25 Option Award |
2018-07-27 5:30 pm |
N/A 2028-07-25 |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO |
77,500 | $0 | 77,500 (Direct) |
View |
| 2018-07-25 Option Award |
2018-07-27 5:29 pm |
N/A 2028-07-25 |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO |
850,000 | $0 | 850,000 (Direct) |
View |
| 2018-07-25 Option Award |
2018-07-27 5:29 pm |
N/A 2020-01-31 |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO |
150,000 | $0 | 850,000 (Direct) |
View |
| 2018-05-02 Option Award |
2018-05-04 4:07 pm |
N/A 2028-05-02 |
Nabriva Therapeutics plc | NBRV | Bourdow Carrie L. Director |
29,000 | $0 | 29,000 (Direct) |
View |
| 2018-05-02 Option Award |
2018-05-04 4:06 pm |
N/A 2028-05-02 |
Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director |
29,000 | $0 | 29,000 (Direct) |
View |
| 2018-05-02 Option Award |
2018-05-04 4:06 pm |
N/A 2028-05-02 |
Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director |
29,000 | $0 | 29,000 (Direct) |
View |
| 2018-05-02 Option Award |
2018-05-04 4:03 pm |
N/A 2028-05-02 |
Nabriva Therapeutics plc | NBRV | CORRIGAN MARK Director |
29,000 | $0 | 29,000 (Direct) |
View |
| 2018-05-02 Option Award |
2018-05-04 4:02 pm |
N/A 2028-05-02 |
Nabriva Therapeutics plc | NBRV | Talbot George Harrison Director |
29,000 | $0 | 29,000 (Direct) |
View |
| 2018-05-02 Option Award |
2018-05-04 4:01 pm |
N/A 2028-05-02 |
Nabriva Therapeutics plc | NBRV | Webster Stephen W Director |
29,000 | $0 | 29,000 (Direct) |
View |
| 2018-03-30 Option Award |
2018-04-03 4:08 pm |
N/A 2028-03-30 |
Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2018-01-31 Option Award |
2018-02-02 4:11 pm |
N/A 2028-01-31 |
Nabriva Therapeutics plc | NBRV | Sender Gary CFO |
100,000 | $0 | 100,000 (Direct) |
View |
| 2018-01-31 Option Award |
2018-02-02 4:11 pm |
N/A 2021-01-31 |
Nabriva Therapeutics plc | NBRV | Sender Gary CFO |
22,500 | $0 | 100,000 (Direct) |
View |
| 2018-01-31 Option Award |
2018-02-02 4:08 pm |
N/A 2028-01-31 |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. Chief Scientific Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2018-01-31 Option Award |
2018-02-02 4:08 pm |
N/A 2021-01-31 |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. Chief Scientific Officer |
22,500 | $0 | 100,000 (Direct) |
View |
| 2018-01-31 Option Award |
2018-02-02 4:07 pm |
N/A 2028-01-31 |
Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2018-01-31 Option Award |
2018-02-02 4:07 pm |
N/A 2021-01-31 |
Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer |
22,500 | $0 | 100,000 (Direct) |
View |
| 2018-01-31 Option Award |
2018-02-02 4:07 pm |
N/A 2028-01-31 |
Nabriva Therapeutics plc | NBRV | Broom Colin MD CEO |
200,000 | $0 | 200,000 (Direct) |
View |
| 2018-01-31 Option Award |
2018-02-02 4:07 pm |
N/A 2021-01-31 |
Nabriva Therapeutics plc | NBRV | Broom Colin MD CEO |
67,500 | $0 | 200,000 (Direct) |
View |
| 2018-01-31 Option Award |
2018-02-02 4:07 pm |
N/A 2028-01-31 |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
100,000 | $0 | 100,000 (Direct) |
View |
| 2018-01-31 Option Award |
2018-02-02 4:07 pm |
N/A 2021-01-31 |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
22,500 | $0 | 100,000 (Direct) |
View |
| 2017-09-27 Exercise |
2017-09-29 7:34 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Talbot George Harrison Director |
1,350 | $0 | 33,140 (Direct) |
View |
| 2017-09-27 Exercise |
2017-09-29 7:34 pm |
N/A 2017-09-27 |
Nabriva Therapeutics plc | NBRV | Talbot George Harrison Director |
1,350 | $0 | 33,140 (Direct) |
View |
| 2017-09-15 Option Award |
2017-09-19 9:33 pm |
N/A 2027-09-15 |
Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director |
10,100 | $0 | 10,100 (Direct) |
View |
| 2017-09-15 Option Award |
2017-09-19 9:32 pm |
N/A 2027-09-15 |
Nabriva Therapeutics plc | NBRV | Bourdow Carrie L. Director |
10,100 | $0 | 10,100 (Direct) |
View |
| 2017-09-15 Option Award |
2017-09-19 9:32 pm |
N/A 2027-09-15 |
Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director |
10,100 | $0 | 10,100 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Sat, 15 Jun 2019 22:01:29 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |